InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Tag-Assisted Peptide Synthesis (TAPS) Services Market”-, By Technology (Chemical Synthesis with Tags, Hybrid Synthesis, C-Terminal Amidation Synthesis), By Application (Therapeutics, Drug Discovery, Research), By End-User (Pharmaceutical and Biotechnology Companies, CDMOs/CROs, Academic and Research Institutes), and Global Forecasts, 2025-2034 And Segment Revenue and Forecast To 2034.”
Global Tag-Assisted Peptide Synthesis (TAPS) Services Market Size is predicted to grow at a 9.2 % CAGR during the forecast period for 2025-2034.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/3107
Tag-Assisted Peptide Synthesis (TAPS) services represent an advanced segment within the contract development and manufacturing industry, utilizing specialized synthesis techniques to efficiently produce structurally complex and low-solubility peptides with enhanced purity compared to conventional methods. This approach employs a detachable solubilizing tag that significantly improves peptide solubility throughout the chain elongation process.
It is particularly well suited for the synthesis of longer peptide sequences (typically exceeding 30 amino acids) as well as sequences prone to aggregation or solubility constraints. By improving compatibility with both aqueous and organic solvent systems, TAPS also streamlines downstream purification processes, particularly high-performance liquid chromatography (HPLC), enabling consistent production of high-quality peptides for therapeutic, industrial, and research applications.
The increasing demand for personalized therapeutics, including neoantigen-based cancer immunotherapies and customized peptide-based treatments, is a key factor driving growth in the custom peptide synthesis market. This trend is further supported by the expanding application of peptides across emerging sectors such as functional nutrition, cosmeceuticals, and advanced diagnostic platforms for biomarker identification.
Ongoing technological progress, particularly in artificial intelligence and machine learning, is accelerating advancements in peptide design and synthesis. These technologies enable more efficient development workflows, reduced production timelines, and improved cost efficiency. At the same time, there is a growing emphasis on sustainable manufacturing practices, with TAPS providers increasingly adopting environmentally responsible measures such as reducing reliance on hazardous solvents like dimethylformamide (DMF), incorporating greener reagents, and implementing waste minimization strategies.
C-terminal amidation is a critical chemical modification in peptide synthesis, involving the conversion of a terminal carboxyl group into an amide functional group, thereby enhancing biological activity, metabolic stability, and therapeutic efficacy. This modification is particularly important in high-throughput screening applications, where amidated peptides demonstrate improved receptor binding and functional performance. The TAPS platform enables efficient integration of C-terminal amidation, supported by solubilizing tags that enhance both synthesis efficiency and purification outcomes.
In academic and research settings, C-terminal amidation plays a vital role in producing peptides that closely replicate native biomolecular structures. Such peptides are widely utilized in proteomics, biomarker discovery, and protein–protein interaction studies. TAPS services therefore provide a reliable and adaptable solution for generating high-purity, application-specific peptides for advanced research activities, including epitope mapping, assay development, and other precision-driven scientific investigations.
Read Comprehensive Report Overview: https://www.insightaceanalytic.com/report/tag-assisted-peptide-synthesis-taps-services-market/3107
List of Prominent Players in the Tag-Assisted Peptide Synthesis (TAPS) Services Market:
- Bachem
- CordenPharma
- Biosynth (Pepscan)
- AmbioPharm
- GenScript
- CPC Scientific
- PolyPeptide Group
- TAG Copenhagen A/S
- CSBio
- Auspep
- BCN Peptides
- Peptide Institute
- Creative Peptides
- Aurigene Services
Market Dynamics
Drivers:
The expanding application of peptide-based therapeutics across multiple therapeutic areas—including oncology, metabolic disorders, cardiovascular diseases, and infectious conditions—is a key factor driving growth in the Tag-Assisted Peptide Synthesis (TAPS) market. Structurally complex peptides, such as cyclic peptides, long-chain sequences, and those containing multiple disulfide linkages, often pose significant limitations for conventional synthesis methods due to challenges related to solubility and conformational stability. TAPS effectively overcomes these constraints by enabling the efficient production of highly complex peptide structures with improved purity and yield.
In addition, the increasing focus on personalized medicine, particularly in the development of neoantigen-based cancer vaccines and patient-specific immunotherapies, is accelerating demand for flexible, scalable, and high-precision peptide synthesis platforms. TAPS is well aligned with these requirements due to its modular workflow design, which allows rapid customization of peptide sequences.
Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) into peptide design and process optimization is enhancing TAPS performance by improving sequence prediction, reducing aggregation risks, and optimizing synthetic pathways. When combined with automation technologies, these advancements significantly enhance throughput, reproducibility, and scalability, positioning TAPS as a critical enabler in next-generation biopharmaceutical manufacturing.
Challenges:
Despite its technological advantages, the adoption of TAPS is associated with certain operational and financial constraints. The requirement for advanced synthesis and purification infrastructure results in high initial capital investment. In addition, the use of proprietary solubilizing tags—such as Molecular Hiving or STag-PS—and high-purity reagents contributes to elevated production costs due to complex manufacturing processes and stringent quality control requirements.
Moreover, effective implementation of TAPS necessitates specialized expertise in peptide chemistry, which may limit accessibility for smaller biotechnology companies and academic research institutions with limited technical and financial resources. Although TAPS offers long-term benefits in terms of efficiency and scalability, these cost and skill-related barriers may restrict broader market penetration, particularly among resource-constrained stakeholders.
Regional Trends:
North America is expected to retain a leading position in the global TAPS market, supported by a mature biopharmaceutical sector, strong research and development infrastructure, and a favorable regulatory environment, particularly in the United States. The region’s high burden of chronic diseases and increasing emphasis on personalized medicine continue to drive demand for advanced peptide synthesis technologies. Contract Development and Manufacturing Organizations (CDMOs) in the region are increasingly integrating TAPS platforms to support the production of complex and customized peptide therapeutics.
In contrast, the Asia-Pacific region is projected to experience the fastest growth over the forecast period. Countries such as China, India, Japan, and South Korea are emerging as key peptide manufacturing hubs, supported by competitive production costs, expanding biotechnology capabilities, and favorable government initiatives promoting innovation. The growing presence of Contract Research Organizations (CROs) and CDMOs in the region is further accelerating the adoption of advanced synthesis technologies such as TAPS, enabling these firms to supply high-complexity peptides to global markets and strengthening the region’s position in the international peptide manufacturing landscape.
Add our site to Google Preferred Sources for quality content: https://google.com/preferences/source?q=insightaceanalytic.com
Recent Developments:
- In November 2024, AmbioPharm broke ground on a $28 million expansion at its Shanghai facility, adding 70,000 ft² of space equipped with multiple 1,000–3,000 L reactors capable of both solid-phase and liquid-phase peptide synthesis (SPPS & LPPS). This expansion is expected to enable the production of over 8 metric tons of crude peptide annually, covering fragment-based peptide synthesis workflows and supporting downstream purification, thereby reinforcing its capacity in Chemical Synthesis with Tags and Hybrid Synthesis.
- In September 2023, CordenPharma stated to have finished many facility improvements and modernizations that have improved the productivity and efficiency of SPPS peptide manufacturing, enabling a greater ability to serve both present and potential clients across an expanding range of pharmaceutical innovators. Upgrades to the current 10,000 l reactor volume with a batch size exceeding 400 kg and an annual capacity of over 2 metric tons of peptide were among the measures put into place; a 50% increase in downstream HPLC purification capacity; automation upgrades; the use of PAT for amino acid identification and intensification of the ready-to-use process with constant washing and reaction monitoring.
Segmentation of Tag-Assisted Peptide Synthesis (TAPS) Services Market.
Global Tag-Assisted Peptide Synthesis (TAPS) Services Market – By Technology
- Chemical Synthesis with Tags
- Hybrid Synthesis
- C-Terminal Amidation Synthesis
Global Tag-Assisted Peptide Synthesis (TAPS) Services Market – By Application
- Therapeutics
- Drug Discovery
- Research
Global Tag-Assisted Peptide Synthesis (TAPS) Services Market – By End-User
- Pharmaceutical and Biotechnology Companies
- CDMOs/CROs
- Academic and Research Institutes
Global Tag-Assisted Peptide Synthesis (TAPS) Services Market – By Region
North America-
- The US
- Canada
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Customize this Study according to your Requirements @ https://www.insightaceanalytic.com/customisation/3107
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
